Join the Oncology Voice Network. Join for Free
Time Audit: YOUR Strategy for Time Management Success
time management strategies time audits productivity enhancement medical affairs professionals work-life balance

Time Audit: YOUR Strategy for Time Management Success


Share This Article


Summary

In this episode, Patrina Pellett joins Tom Caravela to dive into time management strategies for MSLs and medical affairs professionals. They introduce the concept of time audits, a practical tool for enhancing productivity by identifying and eliminating time-wasting activities. Patrina shares personal experiences and outlines a step-by-step guide to conducting a time audit, emphasizing the importance of managing emails and social media. The discussion includes developing an ideal week, handling administrative tasks, and setting boundaries to improve efficiency. Listeners are encouraged to embrace the transformative power of time audits and are provided with a worksheet to get started.

Key Points

  • What is a time audit and how do I go about it
  • Why is a time audit a good idea for time management success
  • What are the challenges to be aware of when make calendar audits and adjustments
  • How can one categorize their calendar items in a time audit and why is it important
  • How does a time audit lead to better work life balance

Click for Source
time management strategies, time audits, productivity enhancement, medical affairs professionals, work-life balance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Fierce Pharma Engage 2025 - RECAP
Partner Avatar MSL Talk: Tom Caravela, Patrina Pellett

Fierce Pharma Engage 2025 - RECAP

Podcast
It Can be Lonely in the Life of an MSL
Partner Avatar MSL Talk: Tom Caravela, Trish Gorecki

It Can be Lonely in the Life of an MSL

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
OVN Avatar R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
OVN Avatar Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Explore OVN